Interestingly, hepatic Rspo3 induction suppressed obesity-induced body weight gain for 7 and 23 days with decreased cumulative food intakes for 7 and 14 days after adenoviral treatment (Fig 3M and 3N). The gene discussed is RSPO3; the disease is obesity disorder.